Benitec Biopharma Ltd Stock Price on August 17, 2020

BNTC Stock  USD 6.86  0.14  2.08%   
Below is the normalized historical share price chart for Benitec Biopharma Ltd extending back to June 23, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Benitec Biopharma stands at 6.86, as last reported on the 24th of April, with the highest price reaching 7.04 and the lowest price hitting 6.57 during the day.
IPO Date
18th of August 2015
200 Day MA
3.6016
50 Day MA
4.9329
Beta
1.024
 
Yuan Drop
 
Covid
If you're considering investing in Benitec Stock, it is important to understand the factors that can impact its price. Benitec Biopharma is very risky given 3 months investment horizon. Benitec Biopharma secures Sharpe Ratio (or Efficiency) of 0.21, which signifies that the company had a 0.21% return per unit of risk over the last 3 months. We were able to interpolate and analyze data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 1.61% are justified by taking the suggested risk. Use Benitec Biopharma Mean Deviation of 4.32, risk adjusted performance of 0.1406, and Downside Deviation of 5.53 to evaluate company specific risk that cannot be diversified away.
  
At present, Benitec Biopharma's Other Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Stock Based Compensation is expected to grow to about 648.3 K, whereas Total Stockholder Equity is forecasted to decline to about 172.7 K. . At present, Benitec Biopharma's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 0, whereas Price Earnings Ratio is forecasted to decline to (0.27). Benitec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.2095

Best PortfolioBest Equity
Good Returns
Average ReturnsBNTC
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 7.71
  actual daily
68
68% of assets are less volatile

Expected Return

 1.61
  actual daily
31
69% of assets have higher returns

Risk-Adjusted Return

 0.21
  actual daily
16
84% of assets perform better
Based on monthly moving average Benitec Biopharma is performing at about 16% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Benitec Biopharma by adding it to a well-diversified portfolio.
Price Book
0.9217
Enterprise Value Ebitda
0.2655
Price Sales
233.7437
Shares Float
M
Wall Street Target Price
16

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

About Benitec Biopharma Stock history

Benitec Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Benitec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Benitec Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Benitec Biopharma stock prices may prove useful in developing a viable investing in Benitec Biopharma
Last ReportedProjected for Next Year
Common Stock Shares Outstanding1.6 M1.7 M
Net Loss-17.6 M-18.5 M

Benitec Biopharma Stock Technical Analysis

Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Benitec Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Benitec Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Benitec Biopharma Period Price Range

Benitec Biopharma April 24, 2024 Market Strength

Market strength indicators help investors to evaluate how Benitec Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Benitec Biopharma shares will generate the highest return on investment. By undertsting and applying Benitec Biopharma stock market strength indicators, traders can identify Benitec Biopharma Ltd entry and exit signals to maximize returns

Benitec Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Benitec Biopharma's price direction in advance. Along with the technical and fundamental analysis of Benitec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Benitec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for Benitec Stock analysis

When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is Benitec Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(236.13)
Revenue Per Share
0.03
Quarterly Revenue Growth
0.125
Return On Assets
(0.82)
Return On Equity
(1.78)
The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.